ORAGENICS, INC. Operating Loss Carryforwards
ORAGENICS, INC. (OGEN) had Operating Loss Carryforwards of $153.58 million as of 2023-12-31, per its 10-K filed 2024-03-29.
Discontinued › Notes › Income Taxes
us-gaap:OperatingLossCarryforwards · last filed 2024-03-29
- 2023-12-31: Operating Loss Carryforwards $153.58M.
- 2022-12-31: Operating Loss Carryforwards $137.73M; Operating Loss Carryforwards as first filed $150.08M.
- 2021-12-31: Operating Loss Carryforwards $145.26M.
- 2020-12-31: Operating Loss Carryforwards $142.89M.
| Period end | Operating Loss Carryforwards | Operating Loss Carryforwards as first filed |
|---|---|---|
| 2023-12-31 | $153.58M 10-K · filed 2024-03-29 | |
| 2022-12-31 | $137.73M 10-K · filed 2024-03-29 | $150.08M 10-K · filed 2023-04-17 |
| 2021-12-31 | $145.26M 10-K/A · filed 2022-07-29 | |
| 2020-12-31 | $142.89M 10-K · filed 2021-03-01 | |
| 2019-12-31 | $117.96M 10-K · filed 2020-03-04 | |
| 2018-12-31 | $102.98M 10-K · filed 2019-03-29 | |
| 2017-12-31 | $93.97M 10-K · filed 2018-02-16 | |
| 2016-12-31 | $87.66M 10-K · filed 2017-02-27 | |
| 2015-12-31 | $81.06M 10-K · filed 2016-03-30 | |
| 2014-12-31 | $69.73M 10-K · filed 2015-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |